|
|
Particulars |
3 Months
ended
30/06/2009 |
3 Months
ended
30/06/2008 |
Financial Year
ended
31/03/2009 |
|
Unaudited |
Unaudited |
Audited |
1. (a) Net Sale/ Income from Operations |
598.38 |
469.12 |
2,181.84 |
|
(b) Other Operating Income |
0 |
0 |
0 |
2. Expenditure |
|
|
|
Increase/ Decrease in Stock in trade and WIP |
-5.69 |
-7.35 |
-29.14 |
Consumption of RM |
53.83 |
61.77 |
650.22 |
Purchase of traded goods |
482.76 |
388.75 |
1347.69 |
Employee Cost |
3.57 |
3.95 |
14.83 |
Depreciation |
8.25 |
7.85 |
31.39 |
Other Expenditure |
7.14 |
7.35 |
26.09 |
Total |
549.86 |
462.32 |
2041.08 |
3. Profit from operations before other income, interest and exceptional items |
48.52 |
6.8 |
140.76 |
4. Other Income |
2.39 |
2.18 |
8.59 |
5. Profit before interest and exceptional items |
50.91 |
8.98 |
149.35 |
6. Interest |
0 |
0 |
0 |
7. Profit after interest but before exceptional items |
50.91 |
8.98 |
149.35 |
8. Exceptional items |
0 |
0 |
0 |
9. Profit (+)/ Loss (-) from ordinary activities before tax |
50.91 |
8.98 |
149.35 |
10. Tax Expense |
0 |
0 |
51.83 |
11. Net Profit (+)/ Loss (-) from Ordinary Activities after tax |
50.91 |
8.98 |
97.52 |
12. Extraordinary Item (net of tax expenses |
0 |
0 |
0 |
13. Net Profit (+)/ Loss (-) for the period |
50.91 |
8.98 |
97.52 |
14. Paid-up Equity Share Capital (Face Value of the Share shall be indicated) |
2207.43 |
2207.43 |
2207.43 |
Face Value of Equity Shares |
1 |
10 |
1 |
15. Reserve excluding Revaluation Reserves as per Balance Sheet of previous year |
|
|
436.73 |
16. Earning Per Share (EPS) |
|
|
|
(a) Basic & Diluted EPS before Extraordinary items for the period, for the year to date and for the previous year (not to be annualised) |
0.02 |
0.04 |
0.04 |
(b) Basic & Diluted EPS after Extraordinary items for the period, for the year to date and for the previous year (not to be annualised) |
0.02 |
0.04 |
0.04 |
17. Public Shareholding |
|
|
|
|
- No. of shares |
133507360 |
131507360 |
131507360 |
|
- Percentage of shareholding |
60.48 |
59.57 |
59.57 |
18. Promoters and promoter group Shareholding |
|
|
|
|
a) Pledged/ Encumbered |
|
|
|
- Number of shares |
0 |
0 |
0 |
- Percentage of shares (as a % of the total shareholding of promoter and promoter group) |
0% |
0% |
0% |
- Percentage of shares (as a% of the total share capital of the company) |
0% |
0% |
0% |
|
b) Non-encumbered |
|
|
|
- Number of Shares |
87235200 |
8923520 |
89235200 |
- Percentage of shares (as a% of the total shareholding of promoter and promoter group) |
100% |
100% |
100% |
- Percentage of shares (as a % of the total share capital of the company) |
39.52% |
40.43% |
40.43% |
Quarterly Reporting Segment wise Revenue,
Results and Capital Employed under Clause 41 of the Listing Agreement |
Particulars |
3 Months
ended
30/06/2009 |
3 Months
ended
30/06/2008 |
Financial Year
ended
31/03/2009 |
|
Unaudited |
Unaudited |
Audited |
(Net Sale/ income from each segment) |
|
|
|
Segment Revenue |
|
|
|
(a) Sale of Pharma & Chemical Products |
492.61 |
396.68 |
1375.19 |
(b) Income from Operation |
95.35 |
62.08 |
755.49 |
(c) IT Activities |
10.42 |
10.36 |
51.16 |
Total |
598.38 |
469.12 |
2181.84 |
Less : Inter Segment Revenue |
0 |
0 |
0 |
Net Sales/ Income from operations |
598.38 |
469.12 |
2181.84 |
Segment Results |
|
|
|
(Profit / Loss before tax and interest from each segment) |
|
|
|
(a) Sale of Pharma & Chemical Products |
39.53 |
7.18 |
128.88 |
(b) Income from Operation |
13.94 |
2.55 |
42.98 |
(c) IT Activities |
0.21 |
0.19 |
3.92 |
Less : Inter Segment Income |
0 |
0 |
0 |
Less: Unallocable Expenditure |
2.77 |
0.94 |
26.43 |
PBT |
50.91 |
8.98 |
149.35 |
